Pediatric ACEs Screening and Resiliency Study (PEARLS)
Fibrinogen Abnormality, Telomere Length, Mean Leukocyte, Atopic
About this trial
This is an interventional screening trial for Fibrinogen Abnormality focused on measuring Adverse Childhood Experiences, Trauma, Social Determinants of Health, Child Mental Health, Resiliency, Primary Care, Universal screening
Eligibility Criteria
Inclusion Criteria:
- English and Spanish-speaking
- Patients receiving a well visit at Primary Care.
- Parents/primary caregivers of the children above, ages 18 and over, who are also legal guardians capable of consent.
Exclusion Criteria:
- Children who are dependents of the court
- Caregiver active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with full participation in the study
- Child or caregiver serious illness (mental or physical; requiring systemic treatment and/or hospitalization) or significant developmental disability that would interfere with full participation in the study
- Inability or unwillingness of subject or legal guardian/representative to give written informed consent.
Sites / Locations
- UCSF Benioff Children's Hospital Oakland
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Experimental
No ACEs screen
Identified ACEs screen with Anticipatory Guidance
De-Identified ACEs screen with Anticipatory Guidance
Participants complete all measures except an ACEs screening tool
Caregiver-completed screening tool about child's adverse experiences.In this version, specific ACEs items are reported, Pediatric medical provider offers anticipatory guidance about ACEs and toxic stress.
Caregiver-completed screening tool about child's adverse experiences. In this version,total number of ACEs items are reported, only. Pediatric medical provider offers anticipatory guidance about ACEs and toxic stress.